Literature DB >> 15552141

Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements.

Arlen D Hanssen1, Mark J Spangehl.   

Abstract

The use of antibiotic-loaded bone cement is an accepted treatment method for infected joint arthroplasties. It is helpful to separate the use of antibiotic-loaded bone cement as a method of prophylaxis as compared with the treatment of an established infection. A low dose of antibiotic-loaded bone cement (< or = 1 g of antibiotic per batch of cement) should be used for prophylaxis, and high-dose antibiotic-loaded bone cement (> 1 g antibiotic per batch of cement) is indicated for treatment. The only commercially available antibiotic-loaded bone cement products are low dose, with the use of tobramycin or gentamicin as an antibiotic selection. High-dose antibiotic-loaded bone cement requires hand mixing by the surgeon to facilitate the use of high dosages and choices of multiple antibiotics. Treatment of infected hip and knee arthroplasties with high-dose antibiotic-loaded bone cement is aided by the use of spacers of various shapes and sizes. These spacers, whether they are static or articulating (mobile), are meant to provide local delivery of antibiotics, stabilization of soft tissues, facilitation of an easier reimplantation, and improved clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15552141     DOI: 10.1097/01.blo.0000143806.72379.7d

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  65 in total

1.  An articulating antibiotic spacer controls infection and improves pain and function in a degenerative septic hip.

Authors:  Erin E Fleck; Mark J Spangehl; Venkat R Rapuri; Christopher P Beauchamp
Journal:  Clin Orthop Relat Res       Date:  2011-11       Impact factor: 4.176

2.  High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE.

Authors:  Joachim Singer; Andreas Merz; Lars Frommelt; Bernd Fink
Journal:  Clin Orthop Relat Res       Date:  2011-11-12       Impact factor: 4.176

3.  Strength of antimicrobial bone cement decreases with increased poragen fraction.

Authors:  Matt Nugent; Alex McLaren; Brent Vernon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2010-08       Impact factor: 4.176

4.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

5.  A preliminary study of the release of quaternary ammonium antimicrobial compounds from acrylic bone cement.

Authors:  Manojgna Mathey; Vijaya Surana; Mark Edwards; John W Nicholson
Journal:  J Mater Sci Mater Med       Date:  2009-03-04       Impact factor: 3.896

6.  Mixing method affects elution and strength of high-dose ALBC: a pilot study.

Authors:  Ryan Miller; Alex McLaren; Christine Leon; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

7.  Antimicrobial Release From Prefabricated Spacers Is Variable and the Dose Is Low.

Authors:  Oren Goltzer; Alex McLaren; Derek Overstreet; Christopher Galli; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2015-07       Impact factor: 4.176

8.  A technique for the fabrication of a reinforced moulded articulating cement spacer in two-stage revision total hip arthroplasty.

Authors:  Matthew Kent; Rajesh Rachha; Manoj Sood
Journal:  Int Orthop       Date:  2009-08-20       Impact factor: 3.075

9.  Salvage of an infected periprosthetic failed fracture fixation in a nonagenarian.

Authors:  Jennifer Hagen; Howard Chansky; Sean E Nork; Lisa A Taitsman
Journal:  Geriatr Orthop Surg Rehabil       Date:  2013-06

Review 10.  Two-stage procedure in the treatment of late chronic hip infections--spacer implantation.

Authors:  Mohamed Sukeik; Fares S Haddad
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.